Tiotropium Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Exacerbation Risk in Asthma
Condition:   Asthma Interventions:   Drug: tiotropium;   Drug: long-acting β2-agonists (LABA);   Drug: inhaled corticosteroids (ICS) Sponsor:   Boehringer Ingelheim Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 15, 2022 Category: Research Source Type: clinical trials